Symptoms of gastroparesis include persistent nausea and vomiting that does not resolve, severe abdominal pain and bloating, inability to eat or keep food down, significant weight loss from malnutrition, and in the worst cases, the need for hospitalization, feeding tubes, or surgical intervention
The FDA has been clear on this
Retatrutide: Phase 2 and TRIUMPH results Retatrutide clinical data comes from two major sources: the Phase 2 obesity trial published in the New England Journal of Medicine, and the recently announced Phase 3 TRIUMPH-4 results
Medical education initiatives enhance physician training in obesity pharmacotherapy management and patient selection criteria
NICE recommends Wegovy as part of specialist weight management services with regular monitoring, typically limiting treatment to a maximum of 2 years